Authors:
Klein, MA
Kaeser, PS
Schwarz, P
Weyd, H
Xenarios, I
Zinkernagel, RM
Carroll, MC
Verbeek, JS
Botto, M
Walport, MJ
Molina, H
Kalinke, U
Acha-Orbea, H
Aguzzi, A
Citation: Ma. Klein et al., Complement facilitates early prion pathogenesis, NAT MED, 7(4), 2001, pp. 488-492
Authors:
Fossati-Jimack, L
Ioan-Facsinay, A
Reininger, L
Chicheportiche, Y
Watanabe, N
Saito, T
Hofhuis, FMA
Gessner, JE
Schiller, C
Schmidt, RE
Honjo, T
Verbeek, JS
Izui, S
Citation: L. Fossati-jimack et al., Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fc gamma receptor III, J EXP MED, 191(8), 2000, pp. 1293-1302
Authors:
Wernersson, S
Karlsson, MCI
Dahlstrom, J
Mattsson, R
Verbeek, JS
Heyman, B
Citation: S. Wernersson et al., IgG-mediated enhancement of antibody responses is low in Fc receptor gammachain-deficient mice and increased in Fc gamma RII-deficient mice, J IMMUNOL, 163(2), 1999, pp. 618-622
Authors:
MacArthur, DLA
de Koning, EJP
Verbeek, JS
Morris, JE
Clark, A
Citation: Dla. Macarthur et al., Amyloid fibril formation is progressive and correlates with beta-cell secretion in transgenic mouse isolated islets, DIABETOLOG, 42(10), 1999, pp. 1219-1227
Authors:
Watanabe, N
Akikusa, B
Park, SY
Ohno, H
Fossati, L
Vecchietti, G
Gessner, JE
Schmidt, RE
Verbeek, JS
Ryffel, B
Iwamoto, I
Izui, S
Saito, T
Citation: N. Watanabe et al., Mast cells induce autoantibody-mediated vasculitis syndrome through tumor necrosis factor production upon triggering Fc gamma receptors, BLOOD, 94(11), 1999, pp. 3855-3863
Authors:
van Egmond, M
van Vuuren, AJH
Morton, HC
van Spriel, AB
Shen, L
Hofhuis, FMA
Saito, T
Mayadas, TN
Verbeek, JS
van de Winkel, JGJ
Citation: M. Van Egmond et al., Human immunoglobulin A receptor (Fc alpha RI, CD89) function in transgenicmice requires both FcR gamma chain and CR3 (CD11b/CD18), BLOOD, 93(12), 1999, pp. 4387-4394